Literature DB >> 33529175

Hierarchical tumor heterogeneity mediated by cell contact between distinct genetic subclones.

Swathi Karthikeyan1, Ian G Waters1, Lauren Dennison1, David Chu1, Joshua Donaldson2, Dong Ho Shin2, D Marc Rosen1, Paula I Gonzalez-Ericsson3,4, Violeta Sanchez2,4, Melinda E Sanders3,4, Morgan V Pantone2, Riley E Bergman2, Brad A Davidson2, Sarah C Reed2, Daniel J Zabransky1, Karen Cravero1, Kelly Kyker-Snowman1, Berry Button1, Hong Yuen Wong2, Paula J Hurley2, Sarah Croessmann2, Ben Ho Park1,2.   

Abstract

Intratumor heterogeneity is an important mediator of poor outcomes in many cancers, including breast cancer. Genetic subclones frequently contribute to this heterogeneity; however, their growth dynamics and interactions remain poorly understood. PIK3CA and HER2 alterations are known to coexist in breast and other cancers. Herein, we present data that describe the ability of oncogenic PIK3CA mutant cells to induce the proliferation of quiescent HER2 mutant cells through a cell contact-mediated mechanism. Interestingly, the HER2 cells proliferated to become the major subclone over PIK3CA counterparts both in vitro and in vivo. Furthermore, this phenotype was observed in both hormone receptor-positive and -negative cell lines, and was dependent on the expression of fibronectin from mutant PIK3CA cells. Analysis of human tumors demonstrated similar HER2:PIK3CA clonal dynamics and fibronectin expression. Our study provides insight into nonrandom subclonal architecture of heterogenous tumors, which may aid the understanding of tumor evolution and inform future strategies for personalized medicine.

Entities:  

Keywords:  Breast cancer; Cell Biology; Molecular biology; Molecular genetics; Oncology

Year:  2021        PMID: 33529175      PMCID: PMC7954606          DOI: 10.1172/JCI143557

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  42 in total

1.  Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures.

Authors:  Jayanta Debnath; Senthil K Muthuswamy; Joan S Brugge
Journal:  Methods       Date:  2003-07       Impact factor: 3.608

2.  Fibronectin and the alpha(5)beta(1) integrin are under developmental and ovarian steroid regulation in the normal mouse mammary gland.

Authors:  T L Woodward; A S Mienaltowski; R R Modi; J M Bennett; S Z Haslam
Journal:  Endocrinology       Date:  2001-07       Impact factor: 4.736

3.  Integrin-dependent activation of MAP kinase: a link to shape-dependent cell proliferation.

Authors:  X Zhu; R K Assoian
Journal:  Mol Biol Cell       Date:  1995-03       Impact factor: 4.138

4.  Integrin-mediated cell adhesion activates mitogen-activated protein kinases.

Authors:  Q Chen; M S Kinch; T H Lin; K Burridge; R L Juliano
Journal:  J Biol Chem       Date:  1994-10-28       Impact factor: 5.157

5.  PIK3CA and AKT1 mutations have distinct effects on sensitivity to targeted pathway inhibitors in an isogenic luminal breast cancer model system.

Authors:  Julia A Beaver; John P Gustin; Kyung H Yi; Anandita Rajpurohit; Matthew Thomas; Samuel F Gilbert; D Marc Rosen; Ben Ho Park; Josh Lauring
Journal:  Clin Cancer Res       Date:  2013-07-25       Impact factor: 12.531

6.  Hotspot SF3B1 mutations induce metabolic reprogramming and vulnerability to serine deprivation.

Authors:  W Brian Dalton; Eric Helmenstine; Noel Walsh; Lukasz P Gondek; Dhanashree S Kelkar; Abigail Read; Rachael Natrajan; Eric S Christenson; Barbara Roman; Samarjit Das; Liang Zhao; Robert D Leone; Daniel Shinn; Taylor Groginski; Anil K Madugundu; Arun Patil; Daniel J Zabransky; Arielle Medford; Justin Lee; Alex J Cole; Marc Rosen; Maya Thakar; Alexander Ambinder; Joshua Donaldson; Amy E DeZern; Karen Cravero; David Chu; Rafael Madero-Marroquin; Akhilesh Pandey; Paula J Hurley; Josh Lauring; Ben Ho Park
Journal:  J Clin Invest       Date:  2019-08-08       Impact factor: 14.808

7.  Activating PIK3CA Mutations Induce an Epidermal Growth Factor Receptor (EGFR)/Extracellular Signal-regulated Kinase (ERK) Paracrine Signaling Axis in Basal-like Breast Cancer.

Authors:  Christian D Young; Lisa J Zimmerman; Daisuke Hoshino; Luigi Formisano; Ariella B Hanker; Michael L Gatza; Meghan M Morrison; Preston D Moore; Corbin A Whitwell; Bhuvanesh Dave; Thomas Stricker; Neil E Bhola; Grace O Silva; Premal Patel; Dana M Brantley-Sieders; Maren Levin; Marina Horiates; Norma A Palma; Kai Wang; Philip J Stephens; Charles M Perou; Alissa M Weaver; Joyce A O'Shaughnessy; Jenny C Chang; Ben Ho Park; Daniel C Liebler; Rebecca S Cook; Carlos L Arteaga
Journal:  Mol Cell Proteomics       Date:  2015-05-07       Impact factor: 5.911

8.  Subclonal diversification of primary breast cancer revealed by multiregion sequencing.

Authors:  Lucy R Yates; Moritz Gerstung; Stian Knappskog; Christine Desmedt; Gunes Gundem; Peter Van Loo; Turid Aas; Ludmil B Alexandrov; Denis Larsimont; Helen Davies; Yilong Li; Young Seok Ju; Manasa Ramakrishna; Hans Kristian Haugland; Peer Kaare Lilleng; Serena Nik-Zainal; Stuart McLaren; Adam Butler; Sancha Martin; Dominic Glodzik; Andrew Menzies; Keiran Raine; Jonathan Hinton; David Jones; Laura J Mudie; Bing Jiang; Delphine Vincent; April Greene-Colozzi; Pierre-Yves Adnet; Aquila Fatima; Marion Maetens; Michail Ignatiadis; Michael R Stratton; Christos Sotiriou; Andrea L Richardson; Per Eystein Lønning; David C Wedge; Peter J Campbell
Journal:  Nat Med       Date:  2015-06-22       Impact factor: 53.440

9.  The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes.

Authors:  Bernard Pereira; Suet-Feung Chin; Oscar M Rueda; Hans-Kristian Moen Vollan; Elena Provenzano; Helen A Bardwell; Michelle Pugh; Linda Jones; Roslin Russell; Stephen-John Sammut; Dana W Y Tsui; Bin Liu; Sarah-Jane Dawson; Jean Abraham; Helen Northen; John F Peden; Abhik Mukherjee; Gulisa Turashvili; Andrew R Green; Steve McKinney; Arusha Oloumi; Sohrab Shah; Nitzan Rosenfeld; Leigh Murphy; David R Bentley; Ian O Ellis; Arnie Purushotham; Sarah E Pinder; Anne-Lise Børresen-Dale; Helena M Earl; Paul D Pharoah; Mark T Ross; Samuel Aparicio; Carlos Caldas
Journal:  Nat Commun       Date:  2016-05-10       Impact factor: 14.919

10.  The evolutionary history of 2,658 cancers.

Authors:  Moritz Gerstung; Clemency Jolly; Ignaty Leshchiner; Stefan C Dentro; Santiago Gonzalez; Daniel Rosebrock; Thomas J Mitchell; Yulia Rubanova; Pavana Anur; Kaixian Yu; Maxime Tarabichi; Amit Deshwar; Jeff Wintersinger; Kortine Kleinheinz; Ignacio Vázquez-García; Kerstin Haase; Lara Jerman; Subhajit Sengupta; Geoff Macintyre; Salem Malikic; Nilgun Donmez; Dimitri G Livitz; Marek Cmero; Jonas Demeulemeester; Steven Schumacher; Yu Fan; Xiaotong Yao; Juhee Lee; Matthias Schlesner; Paul C Boutros; David D Bowtell; Hongtu Zhu; Gad Getz; Marcin Imielinski; Rameen Beroukhim; S Cenk Sahinalp; Yuan Ji; Martin Peifer; Florian Markowetz; Ville Mustonen; Ke Yuan; Wenyi Wang; Quaid D Morris; Paul T Spellman; David C Wedge; Peter Van Loo
Journal:  Nature       Date:  2020-02-06       Impact factor: 49.962

View more
  5 in total

1.  Iron commensalism of mesenchymal glioblastoma promotes ferroptosis susceptibility upon dopamine treatment.

Authors:  Vu T A Vo; Sohyun Kim; Tuyen N M Hua; Jiwoong Oh; Yangsik Jeong
Journal:  Commun Biol       Date:  2022-06-16

2.  Orthotopic Versus Allotopic Implantation: Comparison of Radiological and Pathological Characteristics.

Authors:  YeYu Cai; TaiLi Chen; JiaYi Liu; ShuHui Peng; Huan Liu; Min Lv; ZhuYuan Ding; ZiYi Zhou; Lan Li; Shan Zeng; EnHua Xiao
Journal:  J Magn Reson Imaging       Date:  2021-10-05       Impact factor: 5.119

3.  Chemotoxicity-induced exosomal lncFERO regulates ferroptosis and stemness in gastric cancer stem cells.

Authors:  Haiyang Zhang; Meng Wang; Yi He; Ting Deng; Rui Liu; Weixue Wang; Kegan Zhu; Ming Bai; Tao Ning; Haiou Yang; Ying Liu; Junyi Wang; Yi Ba
Journal:  Cell Death Dis       Date:  2021-11-29       Impact factor: 8.469

4.  ATP11B inhibits breast cancer metastasis in a mouse model by suppressing externalization of nonapoptotic phosphatidylserine.

Authors:  Jun Xu; Sek Man Su; Xin Zhang; Un In Chan; Ragini Adhav; Xiaodong Shu; Jianlin Liu; Jianjie Li; Lihua Mo; Yuqing Wang; Tingting An; Josh Haipeng Lei; Kai Miao; Chu-Xia Deng; Xiaoling Xu
Journal:  J Clin Invest       Date:  2022-03-01       Impact factor: 14.808

Review 5.  The breast is yet to come: current and future utility of circulating tumour DNA in breast cancer.

Authors:  Brad A Davidson; Sarah Croessmann; Ben H Park
Journal:  Br J Cancer       Date:  2021-05-26       Impact factor: 9.075

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.